Ibrahim Adekunle Oreagba
Overview
Explore the profile of Ibrahim Adekunle Oreagba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria
Elemuwa U, Bitrus F, Oreagba I, Osakwe A, Abiodun A, Onu K, et al.
Pharmaceut Med
. 2024 May;
38(3):251-259.
PMID: 38705932
Introduction: Spontaneous reporting of adverse events (AEs) is a mainstay of pharmacovigilance, and an ongoing challenge is how to ensure that more high-quality reports are collected for comprehensive information provision....
2.
Usman S, Oreagba I, Busari A, Akinyede A, Adewumi O, Kadri M, et al.
Saudi Pharm J
. 2022 Jun;
30(5):605-612.
PMID: 35693439
The interplay of artemether-lumefantrine (AL) and atazanavir-ritonavir (ATVr) with Cytochrome (CYP) 3A4 isoenzyme and QTc-interval may spawn clinically significant drug interactions when administered concomitantly. Cardiotoxicity and other adverse effects associated...
3.
Busari A, Oshikoya K, Adejumo I, Olanrewaju O, Usman S, Badru W, et al.
Pan Afr Med J
. 2021 Sep;
39:123.
PMID: 34527139
Introduction: the burden of HIV and tuberculosis co-infection is a global public health challenge. Despite the benefit of isoniazid preventive therapy (IPT) in reducing the rate of co-infection, the uptake...
4.
Usman S, Oreagba I, Kadri M, Adewumi O, Akinyede A, Agbaje E, et al.
Eur J Clin Pharmacol
. 2021 Mar;
77(9):1341-1348.
PMID: 33755736
Purpose: Atazanavir-ritonavir (ATVr)-based antiretroviral therapy and artemether-lumefantrine (AL) are commonly used drugs for the treatment of human immune deficiency virus (HIV) infection and malaria respectively. However, interaction of both drugs,...
5.
Usman S, Oreagba I, Akinyede A, Agbaje E, Akinleye M, Onwujuobi A, et al.
J Pharmacol Sci
. 2020 Sep;
144(3):95-101.
PMID: 32921396
Patients living with HIV in malarial endemic regions may experience clinically significant drug interaction between antiretroviral and antimalarial drugs. Effects of nevirapine (NVP), efavirenz (EFV) and lopinavir/ritonavir (LPVr) on lumefantrine...
6.
Oshikoya K, Ogunyinka I, Ogar C, Abiola A, Ibrahim A, Oreagba I
Ther Adv Drug Saf
. 2020 Feb;
11:2042098620905998.
PMID: 32110375
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions (SCARs). There is scant literature on the characteristics and causes of these conditions among the Nigerian...
7.
Ogar C, Abiola A, Yuah D, Ibrahim A, Oreagba I, Amadi E, et al.
Pharmaceut Med
. 2020 Jan;
33(2):145-157.
PMID: 31933250
Background: Adverse drug reactions (ADRs) are a source of concern in healthcare as they negatively affect patients. Serious adverse drug reactions (SADRs) have an even greater impact on patients and...
8.
Oreagba I, Usman S, Oshikoya K, Akinyede A, Agbaje E, Opanuga O, et al.
J Popul Ther Clin Pharmacol
. 2019 Apr;
26(1):e1-e19.
PMID: 31002484
Background: An important cause of treatment failure to antiretroviral therapy (ART) is the potential interaction between the antiretroviral (ARV) drugs and co-prescribed drugs used concomitantly for the treatment of opportunistic...
9.
Emordi J, Agbaje E, Oreagba I, Iribhogbe O
Adv Pharmacol Sci
. 2018 Dec;
2018:1314941.
PMID: 30532775
Diabetes mellitus has been a menace to mankind from time immemorial. However, a natural product such as P. Beauv (Annonaceae) offers alternative treatment for diabetes mellitus. The study aimed at...
10.
Oshikoya K, Oreagba I, Godman B, Fadare J, Orubu S, Massele A, et al.
Expert Opin Drug Saf
. 2017 Jun;
16(9):981-988.
PMID: 28627939
Background: Prescribing medicines in an off-label manner for children with chronic conditions is sparsely documented, even more so among developing countries. This needs addressing. The objective of this research was...